| Market Cap | ₹3,722Cr |
| ROE | 10.70% |
| P/E Ratio(TTM) | 43.43 |
| EPS(TTM) | 18.61 |
| P/B Ratio | 4.57 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.07 |
| Book Value | 176.75 |
| Debt to Equity | 0.30 |
| Face Value | 10 |
| Parent Organisation | Senores Pharmaceuticals |
| Managing Director | SWAPNIL SHAH |
| Founded | 2017 |
| NSE Symbol | SENORES |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.10 | ||
| Ajanta Pharma | NA (0.00%) | 33.65 | ||
| Gland Pharma | NA (0.00%) | 34.84 | ||
| Eris Lifesciences | NA (0.00%) | 47.73 |